Clinical Review of Staphylococcal Scalded Skin Syndrome in a Single Institution for 18 Years, 2001–2018
- Author:
Seung Jae LEE
1
;
Dong Won LEE
Author Information
1. Department of Pediatrics, Daegu Fatima Hospital, Daegu, Korea. rabitover@hanmail.net
- Publication Type:Original Article
- Keywords:
Glycopeptide;
Methicillin-resistant Staphylococcus aureus;
Staphylococcal scaled skin syndrome;
Staphylococcus aureus
- MeSH:
Child;
Clothing;
Daegu;
Humans;
Medical Records;
Methicillin-Resistant Staphylococcus aureus;
Retrospective Studies;
Skin;
Staphylococcal Scalded Skin Syndrome;
Staphylococcus aureus;
Treatment Outcome
- From:Keimyung Medical Journal
2019;38(1):25-32
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Staphylococcal scalded skin syndrome (SSSS) is a disease caused by exfoliative toxin. The purpose of this study is to analyze clinical features, laboratory findings and treatment outcome of patients who diagnosed with SSSS in a single institution for 18 years. From January 2001 to December 2018, 137 patients were diagnosed with SSSS at Daegu Fatima hospital. We retrospectively reviewed the 131 patients' medical records except 6 patients who were unable to identify the exact medical records. The median age of the patients was 32 months (5 days to 97 months) and 78% of the patients were under 4 years. The mean annual number of cases was 7.3 ± 3.7, the number of patients was increased since 2013, and occurred mainly from August to January. Skin cultures were performed in 62 patients and methicillin-resistant Staphylococcus aureus was cultured in 37 patients. The result of the treatment was good without the dead patient. SSSS is a disease occurred frequently in young children, at August to January. The number of patients was increased since 2013. MRSA was cultured a lot, but uniform use of glycopeptide is not necessary.
